Details
Stereochemistry | EPIMERIC |
Molecular Formula | C20H37N3O13 |
Molecular Weight | 527.5201 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 15 / 16 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12OC4(O[C@]1([H])[C@H](O[C@@]3([H])[C@H](O)[C@@H](N)C[C@@H](NC)[C@@H]3O)O[C@H](CO)[C@@H]2O)O[C@]([H])([C@@H](N)CO)[C@H](O)[C@H](O)[C@H]4O
InChI
InChIKey=GRRNUXAQVGOGFE-SVNOMHMPSA-N
InChI=1S/C20H37N3O13/c1-23-7-2-5(21)9(26)15(10(7)27)33-19-17-16(11(28)8(4-25)32-19)35-20(36-17)18(31)13(30)12(29)14(34-20)6(22)3-24/h5-19,23-31H,2-4,21-22H2,1H3/t5-,6-,7+,8+,9+,10-,11-,12+,13-,14+,15-,16-,17-,18+,19-,20?/m0/s1
Destomycin A is an aminoglycoside antibiotic and is reported to have antibacterial and anthelmintic activity. It has an antibacterial effect on Gram-positive bacteria, Gram-negative bacteria, and fungi. The mode of action of destomycin A is the inhibition of polypeptide synthesis in cells of Escherichia coli and stimulation of adenylate cyclase in several animal tissues. Destomycin A is added to feed for pigs and chickens to prevent parasitic infection of Ascaris suum (the mechanism of action involves inhibition of vitelline coat formation of the parasite eggs.)
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: vitelline coat formation of parasite eggs Sources: http://www.famic.go.jp/ffis/oie/obj/a17_dm.pdf |
|||
Target ID: CHEMBL2095179 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6981528 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18667785
The in vitro antitrypanosomal activity of the 10 microbial metabolites was determined using GUTat 3.1 (T. b. brucei) and STIB900 (T. b. rhodesiense). Destomycin A, was the least active compounds against GUTat 3.1 (IC50 = 330 ng/mL) and STIB900 (IC50 = 210 ng/mL) but its IC50 values can still be considered as active.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QP52AX05
Created by
admin on Sat Dec 16 08:23:20 GMT 2023 , Edited by admin on Sat Dec 16 08:23:20 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
PL7443WI4A
Created by
admin on Sat Dec 16 08:23:20 GMT 2023 , Edited by admin on Sat Dec 16 08:23:20 GMT 2023
|
PRIMARY | |||
|
502206
Created by
admin on Sat Dec 16 08:23:20 GMT 2023 , Edited by admin on Sat Dec 16 08:23:20 GMT 2023
|
PRIMARY | |||
|
14918-35-5
Created by
admin on Sat Dec 16 08:23:20 GMT 2023 , Edited by admin on Sat Dec 16 08:23:20 GMT 2023
|
PRIMARY | |||
|
96877
Created by
admin on Sat Dec 16 08:23:20 GMT 2023 , Edited by admin on Sat Dec 16 08:23:20 GMT 2023
|
PRIMARY | |||
|
DTXSID201016602
Created by
admin on Sat Dec 16 08:23:20 GMT 2023 , Edited by admin on Sat Dec 16 08:23:20 GMT 2023
|
PRIMARY | |||
|
m4206
Created by
admin on Sat Dec 16 08:23:20 GMT 2023 , Edited by admin on Sat Dec 16 08:23:20 GMT 2023
|
PRIMARY | Merck Index |
SUBSTANCE RECORD